Smith & Nephew (LON:SN) Shares Pass Above Two Hundred Day Moving Average - What's Next?

Shares of Smith & Nephew plc (LON:SN - Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,026.34 ($13.52) and traded as high as GBX 1,076.50 ($14.18). Smith & Nephew shares last traded at GBX 1,067.50 ($14.06), with a volume of 1,953,695 shares changing hands.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. reaffirmed an "overweight" rating and issued a GBX 1,180 ($15.55) price target on shares of Smith & Nephew in a report on Tuesday, January 14th.

Smith & Nephew Price Performance

The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84. The stock's fifty day moving average is GBX 1,050.30 and its 200-day moving average is GBX 1,023.68. The stock has a market cap of £11.85 billion, a PE ratio of 38.90, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Smith & Nephew Increases Dividend

The company also recently declared a dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Thursday, March 27th will be given a dividend of $0.23 per share. This represents a dividend yield of 1.61%. The ex-dividend date is Thursday, March 27th. This is a positive change from Smith & Nephew's previous dividend of $0.14. Smith & Nephew's payout ratio is presently 104.41%.

Insider Buying and Selling

In other Smith & Nephew news, insider Jeremy (Jez) Maiden acquired 1,855 shares of the stock in a transaction dated Thursday, May 1st. The stock was acquired at an average price of GBX 1,070 ($14.10) per share, with a total value of £19,848.50 ($26,150.86). Also, insider Sybella Stanley bought 3,810 shares of the business's stock in a transaction that occurred on Wednesday, March 26th. The shares were acquired at an average cost of GBX 1,101 ($14.51) per share, for a total transaction of £41,948.10 ($55,267.59). 0.19% of the stock is currently owned by company insiders.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.